Objective: To reanalyze data from two previous studies to provide stronger evidence of benefit for early use of single-dose intravenous bolus salbutamol in children with acute severe exacerbations ...
[1] The mainstay of treatment of acute asthma in children is 2-adrenergic agents such as salbutamol delivered in frequent high doses or continuously nebulized together with corticosteroids.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results